Absence of spontaneous central nervous system remyelination in class II- deficient mice infected with Theiler's virus

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 1, 1999, Pages 78-91

  Njenga, M Kariuki ^a   Murray, Paul D ^a   McGavern, Dorian ^b   Lin, Xiaoqi ^a   Drescher, Kristen M ^a   Rodriguez, Moses ^a,b  

^a Department of Immunology ^*  (United States)

^b MAYO CLINIC   (United States)

Author keywords

Axonal damage; Cytotoxic CD8+ T cells; Demyelination; MHC class I; MHC Class II; Remyelination; Theiler's murine encephalomyelitis virus

Indexed keywords

CD8 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ANTIBODY;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONICITY; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE FIBER DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; REMYELINIZATION; VIRUS LOAD;

EID: 0032921436     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199901000-00009     Document Type: Article

References (57)

1. Ghatak NR, Leshner RT, Price AC, Felton WL. Remyelination in the human central nervous system. J Neuropath Exp Neurol 1989;48:507-18
2. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: Remyelination of nascent lesion. Ann Neurol 1993;33: 137-51
3. Prineas JW, Kwon EE, Goldenberg PZ, Kyas AA, Quarles RH, Benjamins JA, Sprinkle TJ. Multiple sclerosis: Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 1989;61:489-503
4. Raine CS, Scheinberg L, Waltz JM. Multiple sclerosis: Oligodendrocytes survival and proliferation in an active established lesion. Lab Invest 1981;45:534-46
5. Raine CS, Wu E. Multiple sclerosis: Remyelination in acute lesions. J Neuropath Exp Neurol 1993;52:199-204
6. Blakemore WF. Invasion of Schwann cells into the spinal cord of the rat following local injection of lysolecithin. J Nuropath Appl Neurobiol 1976;2:21-39
7. Ghatak NR, Hirano A, Doron Y, Zimmerman HM. Remyelination in multiple sclerosis with peripheral type myelin. Arch Neurol 1973;29:262-67
8. Itoyama Y, Webster HD, Richardson EP, Jr, Trapp BD. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol 1983;14:339-46
9. Rodriguez M. Multiple sclerosis: Basic concepts and hypotheses. Mayo Clin Proc 1989;64:570-76
10. Luchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-74
11. Rodriguez M, Scheitauer B. Ultrastructure of multiple sclerosis. Ultrastruc Pathol 1994;18:3-13
12. Ludwin SK. Remyelination in the central nervous system and the peripheral nervous system. Adv Neurol 1988;47:215-54
13. Yajima K, Suzuki K. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab Invest 1979;41:385-92
14. Herndon RM, Price DP, Weiner LP. Regeneration of oligodendroglia during recovery from demyelinating disease. Science 1977;195: 693-94
15. Snyder DH, Valsamis MP, Stone SH, Raine CS. Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis. J Neuropath Exp Neurol 1975;34:209-21
16. Barnes R, Munro PMG, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion: A quantitative MRI and electron microscopic study. Brain 1991;114:1271-80
17. Loughlin AJ, Copelman CA, Hall A, Armer T, Young BC, Landon DN, Cuzner ML. Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages. J Neurosc Res 1997;47:384-92
18. McKinnon RD, Piras G, Ida JA, Jr. Dubois-Dalcq M. A role for TGF-beta in oligodendrocyte differentiation. J Cell Biol 1993;121: 1397-407
19. Ozawa K, Suchanak G, Breitschopf H, Bruck W, Budka H, Jellinger K, Lassmann H. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994;117:1311-22
20. Miller DJ, Asakura K, Rodriguez M. Central nervous system re-myelination: Clinical application of basic neuroscience principles. Brain Pathol 1996;6:331-44
21. Njenga MK, Rodriguez M. Animal models of demyelination. Curr Opin Neurol 1996;9:159-64
22. Franklin RJM, Bayley SA, Milner R, Ffrench-Constant C, Blakemore WF. Differentiation of O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter. Glia 1995;13:39-44
23. Komoly S, Hudson LD, Webster HD. Insulin-like growth factor 1 (IGF-1) gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 1992;89:1894-98
24. Yao D-L, Liu X, Hudson LD, Webster HD. Insulin-like growth factor I treatment reduces demyelination and upregulates gene expression of myelin-related proteins in experimental autoimmune encephalitis. Proc Natl Acad Sci USA 1995;92:6190-94
25. 2-microglobulin-deficient mice. J Virol 1993;67:589-92
26. 2-microglobulin. J Immunol 1993;151:266-76
27. Rivera-Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M. Absence of neurologic deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nature Med 1998;4:187-93
28. 2 microglobulin-deficient mice following induced demyelination. J Neurosci 1995;15:8345-52
29. Lipton HL, Dal Canto MC. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol Sci 1976;30:201-7
30. Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol 1996;70:1729-37
31. Rodriguez M, Leibowitz JL, Lamport PW. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 1983;13:426-32
32. Cosgrove D, Gray D, Dierich A, Kaufman J, Lameur M, Benoist C, Mathis D. Mice lacking MHC class II molecules. Cell 1991;66: 1051-66
33. 2m, MHC class I proteins, and CD8+ T cells. Science 1990;148:1227-30
34. Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 1990;27:12-17
35. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 1994;14:6230-38
36. Lin X, Thiemann RL, Pease LR, Rodriguez M. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 1995;214:91-99
37. Matloubian M, Conception RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994;68:8056-63
38. Njenga MK, Asakura K, Hunter SF, Wettstein P, Pease LR, Rodriguez M. The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J Virol 1997;71: 8592-601
39. Asakura K, Miller DJ, Murray K, Bansal R, Pfeiffer SE, Rodriguez M. Monoclonal autoantibody SCH 94.03 which promotes CNS remyelination recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res 1996;43:273-81
40. Miller DJ, Rodriguez M. A monoclonal autoantibody that promotes the central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol 1994;154:2460-69
41. Asakura K, Pogulis RJ, Pease LR, Rodriguez M. A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens. J Neuroimmunol 1996;65:11-19
42. Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the beta 2-microglobulin containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 1997;93:5512-16
43. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. New Engl J Med 1998;338:278-85
44. Lin X, Pease LR, Murray PD, Rodriguez M. Theiler's virus infection of genetically susceptible mice induces central nervous system infiltrating CTLs with no apparent viral or major myelin antigenic specificity. J Immunol 1998;160:5661-68
45. Kowall NW, Kosik KS. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease. Ann Neurol 1987;22:639-43
46. Hiraizumi Y, Fujimaki E, Transfeldt EE, Kawahara N, Fiegel VD, Knighton D, Sung JH. The effect of the platelet-derived wound healing formula and the nerve growth factor on the experimentally injured spinal cord. Spinal Cord 1996;34:394-402
47. Verkade P, Oestreicher AB, Verkleij AJ, Gispen WH. The increase in B-50/GAP-43 in regenerating rat sciatic nerve occurs predominantly in unmyelinated axon shafts: A quantitative ultrastructural study. J Comp Neurol 1995;356:433-43
48. Segal RA, Pomeroy SL, Stiles CD. Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptor in developing cerebellar granule cells. J Neurosci 1995;15:4970-81
49. Ikeda K, Iwasaki Y, Shiojima T, Kinoshita M. Neuroprotective effects of various cytokines on developing spinal motoneurons following axotomy. J Neurol Sci 1996;135:109-13
50. Eichler ME, Dubinsky JM, Tong J, Rich KM. The ability of diphenylpiperazines to prevent neuronal death in dorsal root ganglion neurons in vitro after nerve growth factor deprivation and in vivo after axotomy. J Neurochem 1994;62:2148-57
51. Foster RE, Whalen CC, Waxman SG. Reorganization of the axon membrane in demyelinated peripheral nerve fibers: Morphologic evidence. Science 1980;210:661-63
52. Anthes DL, Theriault E, Tator CH. Characterization of axonal ultrastructural pathology following experimental spinal cord compression injury. Brain Res 1995;702-1-16
53. Rodriguez M, Lindsley MD. Immunosuppression promotes CNS remyelinalion in chronic virus-induced demyelinating disease. Neurology 1992;42:348-57
54. Rodriguez M, Pavelko KD, McKinney CW, Leibowitz JL. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J Immunol 1994;153:3811-21
55. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-80
56. Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J Immunol 1995;155:947-57
57. Njenga MK, Pease LR, Wettstein P, Mak T, Rodriguez M. Interferon α/β mediates early virus-induced expression of H-2D and H-2K in the central nervous system. Lab Invest 1997;77:71-84